Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:13 PM
Study NCT ID:
NCT03596658
Status:
TERMINATED
Last Update Posted:
2022-09-01
First Post:
2018-06-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-14
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-25
First Submit QC Date:
None
Study First Post Date:
2018-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-29
Last Update Post Date:
2022-09-01
Last Update Post Date Type:
ACTUAL